Physician

Samuel Paul Harms, MD

According to 2025 Medicare claims, Samuel Harms, MD (NPI: 1447397799) practices orthopedic surgery in the Duluth, MN-WI market, with the plurality of this provider's patient population coming from St. Louis, MN. This provider's primary affiliated billing organization is ORTHOPEDIC ASSOCIATES OF DULUTH, P.A. (NPI: 1225033715; TIN: 410954165) and primary practice location at 55812-2127. Harms is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Harms' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 182 traditional Medicare patients, billed 1,045 HCPCS/CPT codes, and received $75,031 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 77 prescription claims across 60 beneficiaries totaling $474 in drug costs, led by Oxycodone Hcl (Oxycodone Hcl). DME data shows 19 claims. Open Payments data shows 7 records totaling $259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,922 to $474. For DME billing, reported payments moved sharply higher in recent years, from $772 to $10,102.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	187	1,032	$68,443
2016	199	1,276	$68,742
2017	194	1,158	$80,365
2018	194	1,107	$85,289
2019	204	1,230	$111,735
2020	225	1,352	$109,998
2021	219	1,567	$113,538
2022	218	1,170	$105,948
2023	174	1,140	$69,336
2024	182	1,045	$75,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	94	154	$2,922
2016	103	185	$4,632
2017	115	163	$1,695
2018	147	205	$3,269
2019	171	270	$1,967
2020	171	300	$3,048
2021	180	318	$2,076
2022	87	121	$1,032
2023	56	80	$1,050
2024	60	77	$474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	11	11	$4,800
2023	31	32	$14,838
2024	19	19	$9,491

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	81	$89
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	55	55	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	41	49	$58
20610	Aspiration and/or injection of fluid from large joint	46	56	$46
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	51	239	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone Hcl	Oxycodone Hcl	32	114	$160
Prednisone	Prednisone	14	177	$43

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0935	Continuous passive motion exercise device for use on knee only	Y	19	19	$9,491

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$259	Catalyst OrthoScience
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samuel Paul Harms, MD?

Tedicare shows public-source Medicare data for Samuel Paul Harms, MD (NPI 1447397799), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Paul Harms, MD have ACO affiliation data?

Samuel Paul Harms, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Samuel Paul Harms, MD?

Samuel Paul Harms, MD is linked to ORTHOPEDIC ASSOCIATES OF DULUTH, P.A. (billing NPI 1225033715) in the available physician profile data.

Does Samuel Paul Harms, MD have Open Payments data?

Samuel Paul Harms, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.